ReviewBiomedicines2024

New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes-Beyond and within GLP-1 Receptor Agonists.

Ferenc Sztanek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.